Targeting 'monster cancer cells' could reduce recurrence rates after cancer therapy
MUSC Hollings Cancer Center researchers have unlocked a discovery that could help to explain why cancer can recur in patients who have undergone chemotherapy or radiotherapy.
May 28, 2024
0
2
